Home

Jean Jacques Bienaime, Director: Keros Therapeutics KROS Buy · Filed 04/17

Trade details

Type
Insider buy
Amount
$11,700
Shares · price
1,000 sh · $11.70 a share
Held after
8,450 sh
Trade date
26/04/15
Filed
26/04/17
Days to filing
2 days

First buy since 2023

Insiders buying this week
1 insiders
Holding change
+13.4%

Keros Therapeutics trades, last 26 weeks

What else happened in Keros Therapeutics around then

Filed or reported within 30 days of the trade day · 03/16~05/15

Jean Jacques Bienaime's recent trades

Jean Jacques Bienaime, Director — bought $11.7K of Keros Therapeutics KROS · 1,000 sh @ $11.70 | Whalegun